REG - Integrated Diag Hdgs - Holding(s) in Company

Integrated Diagnostics HoldingsAnnouncement

Yesterday 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260408:nRSH7095Za&default-theme=true

RNS Number : 7095Z  Integrated Diagnostics Holdings PLC  08 April 2026

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

JE00BLKGSR75

Issuer Name

INTEGRATED DIAGNOSTICS HOLDINGS PLC

UK or Non-UK Issuer

Non-UK issuer

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Elliott Investment Management, L.P.

City of registered office (if applicable)

Delaware

Country of registered office (if applicable)

 

4. Details of the shareholder

 Name               City of registered office  Country of registered office
 Actis IDH Limited  Saint Peter Port           Guernsey

5. Date on which the threshold was crossed or reached

31-Mar-2026

6. Date on which Issuer notified

08-Apr-2026

7. Total positions of person(s) subject to the notification obligation

                                                                            % of voting rights attached to shares (total of 8.A)  % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)  Total of both in % (8.A + 8.B)  Total number of voting rights held in issuer
 Resulting situation on the date on which threshold was crossed or reached  21.67%                                                N/A                                                                        21.67%                          125,973,403
 Position of previous notification (if applicable)                          N/A                                                   N/A                                                                        N/A

8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached

8A. Voting rights attached to shares

 Class/Type of shares ISIN code(if possible)  Number of direct voting rights (DTR5.1)  Number of indirect voting rights (DTR5.2.1)  % of direct voting rights (DTR5.1)  % of indirect voting rights (DTR5.2.1)
 GB00B65TLW28                                 N/A                                      125,973,403                                  N/A                                 21.67%
 Sub Total 8.A                                125,973,403                                                                           21.67%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 Type of financial instrument  Expiration date  Exercise/conversion period  Number of voting rights that may be acquired if the instrument is  % of voting rights
                                                                            exercised/converted

 Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))

 Type of financial instrument  Expiration date  Exercise/conversion period  Physical or cash settlement  Number of voting rights  % of voting rights

 Sub Total 8.B2

9. Information in relation to the person subject to the notification
obligation

2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)

 Ultimate controlling person                                              Name of controlled undertaking  % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                                                                                                      than the notifiable threshold
 Paul Singer                                                                                              19.28%                                                                      0.000000                                                                    19.28%
 Elliott Investment Management GP LLC                                                                     19.28%                                                                      0.000000                                                                    19.28%
 Elliott Investment Management LP                                                                         19.28%                                                                      0.000000                                                                    19.28%
 Elliott International Limited                                                                            13.04%                                                                      0.000000                                                                    13.04%
 Elliott International, L.P.                                                                              13.26%                                                                      0.000000                                                                    13.26%
 Elliott Associates, L.P.                                                                                 6.24%                                                                       0.000000                                                                    6.24%
 Devonian ICAV, acting solely on behalf of its sub-fund, Devonian Fund V                                  19.50%                                                                      0.000000                                                                    19.50%
 Ribbon Ventures Limited                                                                                  21.67%                                                                      0.000000                                                                    21.67%
 Actis IDH Limited                                                                                        21.67%                                                                      0.000000                                                                    21.67%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

As announced on 13 November 2025 by Integrated Diagnostics Holdings plc (the
"Company"), Actis GP LLP and Actis Guernsey GP Limited, each, a subsidiary of
Actis LLP and which through funds under their management control shares
representing 21.67% of the Company (the "Actis Shareholding"), have agreed to
dispose, by way of an indirect share sale of Actis IDH Limited, of the entire
Actis Shareholding to a special purpose vehicle, the majority of which is
controlled by funds managed by Elliott Investment Management L.P. (the
"Transaction"). The Transaction, which at the time of the announcement was
conditional on the receipt of regulatory clearance (which was received on 31
March 2026, at which point the transfer became unconditional), will settle on
Thursday 9 April 2026.

12. Date of Completion

08-Apr-2026

13. Place Of Completion

London, United Kingdom

 

 

 

Notes

 

(i) Please note this form should be read jointly with the applicable
Disclosure Guidance and Transparency Rules Chapter 5 (DTR5) available on the
following link: https://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter
(https://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter)

 

(ii) Full name of the legal entity and further specification of the issuer or
underlying issuer, provided it is reliable and accurate (e.g. address, LEI,
domestic number identity). Indicate in the relevant section whether the issuer
is a non UK issuer.

 

(iii) Other reason for the notification could be voluntary notifications,
changes of attribution of the nature of the holding (e.g. expiring of
financial instruments) or acting in concert.

 

(iv) This should be the full name of (a) the shareholder; (b) the natural
person or legal entity acquiring, disposing of or exercising voting rights in
the cases provided for in DTR5.2.1 (b) to (h); (c) all parties to the
agreement referred to in DTR5.2.1 (a) or (d) the holder of financial
instruments referred to in DTR5.3.1.

 

As the disclosure of cases of acting in concert may vary due to the specific
circumstances (e.g. same or different total positions of the parties, entering
or exiting of acting in concert by a single party) the standard form does not
provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in  DTR5.2.1 (b) to (h), the
following list is provided as indication of the persons who should be
mentioned:

 

- in the circumstances foreseen in DTR5.2.1 (b), the natural person or legal
entity that acquires the voting rights and is entitled to exercise them under
the agreement and the natural person or legal entity who is transferring
temporarily for consideration the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (c), the natural person or legal
entity holding the collateral, provided the person or entity controls the
voting rights and declares its intention of exercising them, and natural
person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in DTR5.2.1 (d), the natural person or legal
entity who has a life interest in shares if that person or entity is entitled
to exercise the voting rights attached to the shares and the natural person or
legal entity who is disposing of the voting rights when the life interest is
created;

 

- in the circumstances foreseen in DTR5.2.1 (e), the controlling natural
person or legal entity and, provided it has a notification duty at an
individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a
combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the
shares, if he can exercise the voting rights attached to the shares deposited
with him at his discretion, and the depositor of the shares allowing the
deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in DTR5.2.1 (g), the natural person or legal
entity that controls the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can
exercise the voting rights at his discretion, and the shareholder who has
given his proxy to the proxy holder allowing the latter to exercise the voting
rights at his discretion (e.g. management companies).

 

(v) Applicable in the cases provided for in DTR5.2.1 (b) to (h). This should
be the full name of the shareholder who is the counterparty to the natural
person or legal entity referred to DTR5.2 unless the percentage of voting
rights held by the shareholder is lower than the lowest notifiable threshold
for the disclosure of voting rights holdings in accordance with national
practices (e.g. identification of funds managed by management companies).

 

(vi) The date on which threshold is crossed or reached should be the date on
which the acquisition or disposal took place or the other reason triggered the
notification obligation. For passive crossings, the date when the corporate
event took effect.

 

(vii) The total number of voting rights held in the issuer shall be composed
of all the shares, including depository receipts representing shares, to which
voting rights are attached even if the exercise thereof is suspended.

 

(viii) If the holding has fallen below the lowest applicable threshold, please
note that it might not be necessary to disclose the extent of the holding,
only that the new holding is below that threshold.

 

(ix) In case of combined holdings of shares with voting rights attached
"direct holding" and voting rights "indirect holding", please split the voting
rights number and percentage into the direct and indirect columns - if there
is no combined holdings, please leave the relevant box blank.

 

(x) Date of maturity/expiration of the financial instrument i.e. the date when
right to acquire shares ends.

 

(xi) If the financial instrument has such a period - please specify this
period - for example once every 3 months starting from  date .

 

(xii) In case of cash settled instruments the number and percentages of voting
rights is to be presented on a delta-adjusted basis (DTR 5.3.3.A).

 

(xiii) If the person subject to the notification obligation is either
controlled and/or does control another undertaking then the second option
applies.

 

(xiv) The full chain of controlled undertakings starting with the ultimate
controlling natural person or legal entity has to be presented also in the
cases, in which only on subsidiary level a threshold is crossed or reached and
the subsidiary undertaking discloses the notification as only in this way will
the markets get always the full picture of the group holdings. In case of
multiple chains through which the voting rights and/or financial instruments
are effectively held the chains have to be presented chain by chain by
numbering each chain accordingly. Please see the below example:

Name of ultimate controlling person A (chain 1)

Name of controlled undertaking B

Name of controlled undertaking C

Name of ultimate controlling person A (chain 2)

Name of controlled undertaking B

Name of controlled undertaking D

Name of ultimate controlling person A (chain3)

Name of controlled undertaking E

Name of controlled undertaking F

 

(xv) The names of controlled undertakings through which the voting rights
and/or financial instruments are effectively held have to be presented
irrespectively whether the controlled undertakings cross or reach the lowest
applicable threshold themselves.

 

(xvi) Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLUWSNRNKUSRAR



            Copyright 2019 Regulatory News Service, all rights reserved